MEDIFAST INC Operating Income Loss

• MEDIFAST INC showed a decrease of -593.8% in Operating Income Loss from 2024 to 2025.
• This data is from MEDIFAST INC's annual report (Form 10-K), filed with the SEC on February 17, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2009 to 2025), MEDIFAST INC's Operating Income Loss has declined by 176.8%.
• Historical annual values: Fiscal year 2025: -$14.21 million | Fiscal year 2024: $2.88 million | Fiscal year 2023: $126.40 million | Fiscal year 2022: $184.81 million | Fiscal year 2021: $216.24 million | Fiscal year 2020: $134.16 million | Fiscal year 2019: $91.04 million | Fiscal year 2018: $69.06 million | Fiscal year 2017: $39.63 million | Fiscal year 2016: $26.86 million | Fiscal year 2015: $28.68 million | Fiscal year 2014: $30.25 million | Fiscal year 2013: $38.41 million | Fiscal year 2012: $27.14 million | Fiscal year 2011: $27.38 million | Fiscal year 2010: $31.64 million | Fiscal year 2009: $18.50 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026